XML 55 R22.htm IDEA: XBRL DOCUMENT v2.4.0.8
Supplemental Guarantor and Non-Guarantor Financial Information
3 Months Ended
Mar. 31, 2014
Supplemental Guarantor and Non-Guarantor Financial Information [Abstract]  
Supplemental Guarantor and Non-Guarantor Financial Information
Supplemental Guarantor and Non-Guarantor Financial Information
Gentiva’s guarantor subsidiaries are guarantors to the Company’s debt securities which are registered under the Securities Act of 1933, as amended. The condensed consolidating financial statements presented below are provided pursuant to Rule 3-10 of Regulation S-X. Separate financial statements of each subsidiary guaranteeing Gentiva’s debt securities are not presented because the guarantor subsidiaries are jointly and severally, fully and unconditionally liable under the guarantees, and 100 percent owned by the Company. There are no restrictions on the ability to obtain funds from these subsidiaries by dividends or other means.
The following condensed consolidating financial statements include the balance sheets as of March 31, 2014 and December 31, 2013, statements of comprehensive income for the three months ended March 31, 2014 and 2013 and statements of cash flows for the three months ended March 31, 2014 and 2013 of (i) Gentiva Health Services, Inc. and (ii) its guarantor subsidiaries (in each case, reflecting investments in its consolidated subsidiaries under the equity method of accounting) and its non-guarantor subsidiaries along with eliminations necessary to arrive at the information for the Company on a consolidated basis.

Condensed Consolidating Balance Sheet
March 31, 2014
(In thousands)
 
 
Gentiva Health
Services, Inc.
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Total
ASSETS
 
 
 
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
31,002

 
$

 
$
31,882

 
$

 
$
62,884

Receivables, net

 
285,494

 
53,558

 
(47,714
)
 
291,338

Deferred tax assets, net

 
22,848

 
3,242

 

 
26,090

Prepaid expenses and other current assets

 
55,939

 
10,729

 

 
66,668

Total current assets
31,002

 
364,281

 
99,411

 
(47,714
)
 
446,980

Notes receivable from CareCentrix

 
28,471

 

 

 
28,471

Fixed assets, net

 
46,612

 
576

 

 
47,188

Intangible assets, net

 
252,132

 
2,600

 

 
254,732

Goodwill

 
381,150

 
8,931

 

 
390,081

Investment in subsidiaries
813,960

 
29,125

 

 
(843,085
)
 

Other assets
27,012

 
40,463

 
7

 

 
67,482

Total assets
$
871,974

 
$
1,142,234

 
$
111,525

 
$
(890,799
)
 
$
1,234,934

 
 
 
 
 
 
 
 
 
 
LIABILITIES AND EQUITY
 
 
 
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
 
 
 
Current portion of long-term debt
$
47,263

 
$

 
$

 
$

 
$
47,263

Accounts payable

 
55,670

 

 
(43,074
)
 
12,596

Other current liabilities
1,917

 
212,335

 
78,296

 
(4,640
)
 
287,908

Total current liabilities
49,180

 
268,005

 
78,296

 
(47,714
)
 
347,767

Long-term debt
1,118,197

 

 

 

 
1,118,197

Deferred tax liabilities, net

 
14,711

 

 

 
14,711

Other liabilities
6,285

 
45,558

 

 

 
51,843

Total Gentiva shareholders’ (deficit) equity
(301,688
)
 
813,960

 
29,125

 
(843,085
)
 
(301,688
)
Noncontrolling interests

 

 
4,104

 

 
4,104

Total (deficit) equity
(301,688
)
 
813,960

 
33,229

 
(843,085
)
 
(297,584
)
Total liabilities and equity (deficit)
$
871,974

 
$
1,142,234

 
$
111,525

 
$
(890,799
)
 
$
1,234,934

Condensed Consolidating Balance Sheet
December 31, 2013
(In thousands)
 
 
Gentiva Health
Services, Inc.
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Total
ASSETS
 
 
 
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
55,076

 
$

 
$
31,881

 
$

 
$
86,957

Receivables, net

 
284,379

 
34,136

 
(28,610
)
 
289,905

Deferred tax assets, net

 
25,845

 
2,308

 

 
28,153

Prepaid expenses and other current assets

 
50,890

 
13,856

 

 
64,746

Total current assets
55,076

 
361,114

 
82,181

 
(28,610
)
 
469,761

Note receivable from CareCentrix

 
28,471

 

 

 
28,471

Fixed assets, net

 
48,824

 
551

 

 
49,375

Intangible assets, net

 
253,682

 
2,600

 

 
256,282

Goodwill

 
384,017

 
6,064

 

 
390,081

Investment in subsidiaries
791,456

 
28,382

 

 
(819,838
)
 

Other assets
28,266

 
40,370

 
11

 

 
68,647

Total assets
$
874,798

 
$
1,144,860

 
$
91,407

 
$
(848,448
)
 
$
1,262,617

 
 
 
 
 
 
 
 
 
 
LIABILITIES AND EQUITY
 
 
 
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
 
 
 
Current portion of long-term debt
$
45,325

 
$

 
$

 
$

 
$
45,325

Accounts payable

 
15,377

 
282

 

 
15,659

Other current liabilities
188

 
283,040

 
59,868

 
(28,610
)
 
314,486

Total current liabilities
45,513

 
298,417

 
60,150

 
(28,610
)
 
375,470

Long-term debt
1,124,432

 

 

 

 
1,124,432

Deferred tax liabilities, net

 
9,825

 

 

 
9,825

Other liabilities
7,922

 
45,162

 

 

 
53,084

Total Gentiva shareholders’ (deficit) equity
(303,069
)
 
791,456

 
28,382

 
(819,838
)
 
(303,069
)
Noncontrolling interests

 

 
2,875

 

 
2,875

Total (deficit) equity
(303,069
)
 
791,456

 
31,257

 
(819,838
)
 
(300,194
)
Total liabilities and equity (deficit)
$
874,798

 
$
1,144,860

 
$
91,407

 
$
(848,448
)
 
$
1,262,617


Condensed Consolidating Statement of Comprehensive Income
For the Three Months Ended March 31, 2014
(In thousands)
 
 
Gentiva Health
Services, Inc.
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Total
Net revenues
$

 
$
474,694

 
$
17,945

 
$
(5,134
)
 
$
487,505

Cost of services sold

 
266,093

 
12,109

 
(5,134
)
 
273,068

Gross profit

 
208,601

 
5,836

 

 
214,437

Selling, general and administrative expenses

 
(183,887
)
 
(5,133
)
 

 
(189,020
)
Interest (expense) and other, net
(24,550
)
 

 
52

 

 
(24,498
)
Equity in earnings of subsidiaries
15,911

 
254

 

 
(16,165
)
 

(Loss) income before income taxes
(8,639
)
 
24,968

 
755

 
(16,165
)
 
919

Income tax benefit (expense)
8,953

 
(9,057
)
 
(317
)
 

 
(421
)
Net income
314

 
15,911

 
438

 
(16,165
)
 
498

Noncontrolling interests

 

 
(184
)
 

 
(184
)
Net income attributable to Gentiva shareholders
$
314

 
$
15,911

 
$
254

 
$
(16,165
)
 
$
314

Total comprehensive income
$
314

 
$
15,911

 
$
438

 
$
(16,165
)
 
$
498

Condensed Consolidating Statement of Comprehensive Income (Loss)
For the Three Months Ended March 31, 2013
(In thousands)
 
Gentiva Health
Services, Inc.
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Total
Net revenues
$

 
$
403,144

 
$
15,626

 
$
(3,179
)
 
$
415,591

Cost of services sold

 
213,202

 
11,550

 
(3,179
)
 
221,573

Gross profit

 
189,942

 
4,076

 

 
194,018

Selling, general and administrative expenses

 
(155,249
)
 
(4,628
)
 

 
(159,877
)
Goodwill and other long-lived asset impairment

 
(224,320
)
 

 

 
(224,320
)
Interest (expense) and other, net
(22,310
)
 

 
17

 

 
(22,293
)
Equity in earnings of subsidiaries
(193,791
)
 
(397
)
 

 
194,188

 

Loss before income taxes
(216,101
)
 
(190,024
)
 
(535
)
 
194,188

 
(212,472
)
Income tax benefit (expense)
8,924

 
(3,767
)
 
259

 

 
5,416

Net loss
(207,177
)
 
(193,791
)
 
(276
)
 
194,188

 
(207,056
)
Noncontrolling interests

 

 
(121
)
 

 
(121
)
Net loss attributable to Gentiva shareholders
$
(207,177
)
 
$
(193,791
)
 
$
(397
)
 
$
194,188

 
$
(207,177
)
Total comprehensive loss
$
(207,177
)
 
$
(193,791
)
 
$
(276
)
 
$
194,188

 
$
(207,056
)
 


 

Condensed Consolidating Statement of Cash Flows
For the Three Months Ended March 31, 2014
(In thousands)
 
 
Gentiva Health
Services, Inc.
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Total
OPERATING ACTIVITIES:
 
 
 
 
 
 
 
 
 
Net cash used in operating activities
$
(11,806
)
 
$
(5,012
)
 
$
(597
)
 
$
(328
)
 
$
(17,743
)
INVESTING ACTIVITIES:
 
 
 
 
 
 
 
 
 
Purchase of fixed assets

 
(3,104
)
 
(54
)
 

 
(3,158
)
Proceeds from sale of assets

 
191

 

 

 
191

Net cash used in investing activities

 
(2,913
)
 
(54
)
 

 
(2,967
)
FINANCING ACTIVITIES:
 
 
 
 
 
 
 
 
 
Proceeds from issuance of common stock
597

 

 

 

 
597

Windfall tax benefits associated with equity-based compensation
6

 

 

 

 
6

Repayment of long-term debt
(4,581
)
 

 

 

 
(4,581
)
Minority interest capital contributions

 

 
1,160

 


 
1,160

Distribution to minority interests

 

 
(115
)
 


 
(115
)
Distribution to majority interests

 

 
(328
)
 
328

 

Other
(337
)
 
(28
)
 
(65
)
 

 
(430
)
Net payments related to intercompany financing
(7,953
)
 
7,953

 

 

 

Net cash (used in) provided by financing activities
(12,268
)
 
7,925

 
652

 
328

 
(3,363
)
Net change in cash and cash equivalents
(24,074
)
 

 
1

 

 
(24,073
)
Cash and cash equivalents at beginning of period
55,076

 

 
31,881

 

 
86,957

Cash and cash equivalents at end of period
$
31,002

 
$

 
$
31,882

 
$

 
$
62,884


Condensed Consolidating Statement of Cash Flows
For the Three Months Ended March 31, 2013
(In thousands)
 
 
Gentiva Health
Services, Inc.
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Total
OPERATING ACTIVITIES:
 
 
 
 
 
 
 
 
 
Net cash (used in) provided by operating activities
$
(8,314
)
 
$
(13,821
)
 
$
1,575

 
$

 
$
(20,560
)
INVESTING ACTIVITIES:
 
 
 
 
 
 
 
 
 
Purchase of fixed assets

 
(2,646
)
 
(52
)
 

 
(2,698
)
Net cash used in investing activities

 
(2,646
)
 
(52
)
 

 
(2,698
)
FINANCING ACTIVITIES:
 
 
 
 
 
 
 
 
 
Proceeds from issuance of common stock
992

 

 

 

 
992

Windfall tax benefits associated with equity-based compensation
72

 

 

 

 
72

Repayment of long-term debt
(25,000
)
 

 

 

 
(25,000
)
Debt issuance costs

 

 

 

 

Distribution to minority interests
387

 
(28
)
 
(599
)
 

 
(240
)
Other
(23
)
 

 

 

 
(23
)
Net payments related to intercompany financing
(16,495
)
 
16,495

 

 

 

Net cash (used in) provided by financing activities
(40,067
)
 
16,467

 
(599
)
 

 
(24,199
)
Net change in cash and cash equivalents
(48,381
)
 

 
924

 

 
(47,457
)
Cash and cash equivalents at beginning of period
166,140

 

 
40,912

 

 
207,052

Cash and cash equivalents at end of period
$
117,759

 
$

 
$
41,836

 
$

 
$
159,595